73 related articles for article (PubMed ID: 22692738)
21. Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans.
Tang XL; Hua Y; Guan Q; Yuan CH
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):587-95. PubMed ID: 26810058
[TBL] [Abstract][Full Text] [Related]
22. Call for a California coccidioidomycosis consortium to face the top ten challenges posed by a recalcitrant regional disease.
Thompson GR; Stevens DA; Clemons KV; Fierer J; Johnson RH; Sykes J; Rutherford G; Peterson M; Taylor JW; Chaturvedi V
Mycopathologia; 2015 Feb; 179(1-2):1-9. PubMed ID: 25318989
[TBL] [Abstract][Full Text] [Related]
23. Molecular and nonmolecular diagnostic methods for invasive fungal infections.
Arvanitis M; Anagnostou T; Fuchs BB; Caliendo AM; Mylonakis E
Clin Microbiol Rev; 2014 Jul; 27(3):490-526. PubMed ID: 24982319
[TBL] [Abstract][Full Text] [Related]
24. Update on fungal diagnostics.
Griffin AT; Hanson KE
Curr Infect Dis Rep; 2014 Aug; 16(8):415. PubMed ID: 24893982
[TBL] [Abstract][Full Text] [Related]
25. Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.
Wood BR; Komarow L; Zolopa AR; Finkelman MA; Powderly WG; Sax PE
AIDS; 2013 Mar; 27(6):967-972. PubMed ID: 23698062
[TBL] [Abstract][Full Text] [Related]
26. A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.
He S; Hang JP; Zhang L; Wang F; Zhang DC; Gong FH
J Microbiol Immunol Infect; 2015 Aug; 48(4):351-61. PubMed ID: 25081986
[TBL] [Abstract][Full Text] [Related]
27. [Problems and recent advances in measurement of (1-->3)-beta-D-glucan].
Yoshida K; Shoji H; Niki Y
Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):75-80. PubMed ID: 18451587
[TBL] [Abstract][Full Text] [Related]
28. Serum (1->3)-β-D-glucan measurement in coccidioidomycosis.
Thompson GR; Bays DJ; Johnson SM; Cohen SH; Pappagianis D; Finkelman MA
J Clin Microbiol; 2012 Sep; 50(9):3060-2. PubMed ID: 22692738
[TBL] [Abstract][Full Text] [Related]
29. Reappraisal of the serum (1-->3)-beta-D-glucan assay for the diagnosis of invasive fungal infections--a study based on autopsy cases from 6 years.
Obayashi T; Negishi K; Suzuki T; Funata N
Clin Infect Dis; 2008 Jun; 46(12):1864-70. PubMed ID: 18462174
[TBL] [Abstract][Full Text] [Related]
30. Positive (1-3) B-d-glucan and cross reactivity of fungal assays in coccidioidomycosis.
Zangeneh TT; Malo J; Luraschi-Monjagatta C; Hage CA; Wheat LJ; Strawter C; Klotz SA; Knox KS
Med Mycol; 2015 Feb; 53(2):171-3. PubMed ID: 25541557
[TBL] [Abstract][Full Text] [Related]
31. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.
Ostrosky-Zeichner L; Alexander BD; Kett DH; Vazquez J; Pappas PG; Saeki F; Ketchum PA; Wingard J; Schiff R; Tamura H; Finkelman MA; Rex JH
Clin Infect Dis; 2005 Sep; 41(5):654-9. PubMed ID: 16080087
[TBL] [Abstract][Full Text] [Related]
32. [Utility of galactomannan enzyme immunoassay and (1,3)beta-D-glucan assay in invasive fungal infection].
Yu J; Li RY; Gao LJ; Lu QY; Wang XH
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):371-4. PubMed ID: 20367931
[TBL] [Abstract][Full Text] [Related]
33. The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.
Alexander BD; Smith PB; Davis RD; Perfect JR; Reller LB
J Clin Microbiol; 2010 Nov; 48(11):4083-8. PubMed ID: 20720025
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis.
Kirsch EJ; Greene RT; Prahl A; Rubin SI; Sykes JE; Durkin MM; Wheat LJ
Clin Vaccine Immunol; 2012 Mar; 19(3):343-5. PubMed ID: 22278324
[TBL] [Abstract][Full Text] [Related]
35. Geographic distribution of endemic fungal infections among older persons, United States.
Baddley JW; Winthrop KL; Patkar NM; Delzell E; Beukelman T; Xie F; Chen L; Curtis JR
Emerg Infect Dis; 2011 Sep; 17(9):1664-9. PubMed ID: 21888792
[TBL] [Abstract][Full Text] [Related]
36. Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis.
Thompson GR; Lunetta JM; Johnson SM; Taylor S; Bays D; Cohen SH; Pappagianis D
Clin Infect Dis; 2011 Sep; 53(6):e20-4. PubMed ID: 21865185
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
